Exact Sciences Statistics
Total Valuation
Exact Sciences has a market cap or net worth of $8.44 billion. The enterprise value is $10.19 billion.
Important Dates
The next confirmed earnings date is Thursday, May 1, 2025, after market close.
| Earnings Date | May 1, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Exact Sciences has 185.76 million shares outstanding. The number of shares has increased by 2.25% in one year.
| Current Share Class | 185.76M |
| Shares Outstanding | 185.76M |
| Shares Change (YoY) | +2.25% |
| Shares Change (QoQ) | +0.28% |
| Owned by Insiders (%) | 0.76% |
| Owned by Institutions (%) | 100.18% |
| Float | 184.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 149.72 |
| PS Ratio | 3.04 |
| Forward PS | 2.71 |
| PB Ratio | 3.52 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 113.33 |
| P/OCF Ratio | 40.13 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 342.26, with an EV/FCF ratio of 136.64.
| EV / Earnings | n/a |
| EV / Sales | 3.69 |
| EV / EBITDA | 342.26 |
| EV / EBIT | n/a |
| EV / FCF | 136.64 |
Financial Position
The company has a current ratio of 2.15, with a Debt / Equity ratio of 1.16.
| Current Ratio | 2.15 |
| Quick Ratio | 1.76 |
| Debt / Equity | 1.16 |
| Debt / EBITDA | 38.74 |
| Debt / FCF | 37.24 |
| Interest Coverage | -6.85 |
Financial Efficiency
Return on equity (ROE) is -37.09% and return on invested capital (ROIC) is -2.12%.
| Return on Equity (ROE) | -37.09% |
| Return on Assets (ROA) | -1.87% |
| Return on Invested Capital (ROIC) | -2.12% |
| Return on Capital Employed (ROCE) | -3.56% |
| Revenue Per Employee | $394,124 |
| Profits Per Employee | -$146,980 |
| Employee Count | 7,000 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 5.80 |
Taxes
| Income Tax | -7.30M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.12% in the last 52 weeks. The beta is 1.14, so Exact Sciences's price volatility has been higher than the market average.
| Beta (5Y) | 1.14 |
| 52-Week Price Change | -28.12% |
| 50-Day Moving Average | 45.78 |
| 200-Day Moving Average | 55.79 |
| Relative Strength Index (RSI) | 53.06 |
| Average Volume (20 Days) | 2,778,928 |
Short Selling Information
The latest short interest is 11.17 million, so 6.01% of the outstanding shares have been sold short.
| Short Interest | 11.17M |
| Short Previous Month | 10.60M |
| Short % of Shares Out | 6.01% |
| Short % of Float | 6.06% |
| Short Ratio (days to cover) | 5.50 |
Income Statement
In the last 12 months, Exact Sciences had revenue of $2.76 billion and -$1.03 billion in losses. Loss per share was -$5.59.
| Revenue | 2.76B |
| Gross Profit | 1.92B |
| Operating Income | -185.10M |
| Pretax Income | -172.10M |
| Net Income | -1.03B |
| EBITDA | 29.76M |
| EBIT | -185.10M |
| Loss Per Share | -$5.59 |
Full Income StatementBalance Sheet
The company has $1.04 billion in cash and $2.78 billion in debt, giving a net cash position of -$1.74 billion or -$9.35 per share.
| Cash & Cash Equivalents | 1.04B |
| Total Debt | 2.78B |
| Net Cash | -1.74B |
| Net Cash Per Share | -$9.35 |
| Equity (Book Value) | 2.40B |
| Book Value Per Share | 12.94 |
| Working Capital | 839.24M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $210.54 million and capital expenditures -$135.99 million, giving a free cash flow of $74.55 million.
| Operating Cash Flow | 210.54M |
| Capital Expenditures | -135.99M |
| Free Cash Flow | 74.55M |
| FCF Per Share | $0.40 |
Full Cash Flow StatementMargins
Gross margin is 69.55%, with operating and profit margins of -6.71% and -37.29%.
| Gross Margin | 69.55% |
| Operating Margin | -6.71% |
| Pretax Margin | -37.56% |
| Profit Margin | -37.29% |
| EBITDA Margin | 1.08% |
| EBIT Margin | -6.71% |
| FCF Margin | 2.70% |
Dividends & Yields
Exact Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.25% |
| Shareholder Yield | -2.25% |
| Earnings Yield | -12.18% |
| FCF Yield | 0.88% |
Dividend DetailsAnalyst Forecast
The average price target for Exact Sciences is $68.95, which is 51.67% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $68.95 |
| Price Target Difference | 51.67% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 20 |
| Revenue Growth Forecast (5Y) | 10.83% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Exact Sciences has an Altman Z-Score of 1.32 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.32 |
| Piotroski F-Score | 3 |